Using the 4S-AF scheme to characterize new-onset atrial fibrillation after myocardial infarction
- PMID: 37169632
- DOI: 10.1016/j.ejim.2023.05.004
Using the 4S-AF scheme to characterize new-onset atrial fibrillation after myocardial infarction
Conflict of interest statement
Declaration of Competing Interest JD: None declared; TP: None declared; GYHL: Consultant and speaker for BMS/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Anthos. No fees are received personally. GYHL is co-principal investigator of the AFFIRMO project on multimorbidity in AF, which has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 899871.
Comment on
-
Prognostic implications of the 4S-AF scheme to characterize new-onset atrial fibrillation after myocardial infarction.Eur J Intern Med. 2023 Jul;113:38-44. doi: 10.1016/j.ejim.2023.04.003. Epub 2023 Apr 8. Eur J Intern Med. 2023. PMID: 37037721
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
